These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23248410)

  • 1. Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats.
    Zaitone SA; Abo-Elmatty DM; Elshazly SM
    Indian J Pharmacol; 2012; 44(6):774-9. PubMed ID: 23248410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
    Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
    Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.
    Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA
    Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapy.
    Zaitone SA; Ahmed E; Elsherbiny NM; Mehanna ET; El-Kherbetawy MK; ElSayed MH; Alshareef DM; Moustafa YM
    Pharmacol Rep; 2019 Feb; 71(1):32-41. PubMed ID: 30368226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effects of Eexenatide in a Rotenone-Induced Rat Model of Parkinson's Disease.
    Aksoy D; Solmaz V; Çavuşoğlu T; Meral A; Ateş U; Erbaş O
    Am J Med Sci; 2017 Sep; 354(3):319-324. PubMed ID: 28918840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
    Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R
    Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of evening primrose oil on behavioral activities, nigral microglia and histopathological changes in a rat model of rotenone-induced parkinsonism.
    Mohammad HMF; El-Baz AA; Mahmoud OM; Khalil S; Atta R; Imbaby S
    J Chem Neuroanat; 2023 Jan; 127():102206. PubMed ID: 36464068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, Biochemical and Histopathological effects of Standardised Pomegranate extract with Vinpocetine, Propolis or Cocoa in a rat model of Parkinson's disease.
    Ali AA; Kamal MM; Khalil MG; Ali SA; Elariny HA; Bekhit A; Wahid A
    Exp Aging Res; 2022; 48(2):191-210. PubMed ID: 34384037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-κβ and Caspase-3.
    Zaafan MA; Abdelhamid AM; Ibrahim SM
    Curr Pharm Biotechnol; 2019; 20(7):588-594. PubMed ID: 31198107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
    Ishola IO; Awogbindin IO; Olubodun-Obadun TG; Olajiga AE; Adeyemi OO
    Neurotoxicology; 2023 May; 96():37-52. PubMed ID: 36965781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective effect of erythropoietin on experimental Parkinson model in rats.
    Erbaş O; Çınar BP; Solmaz V; Çavuşoğlu T; Ateş U
    Neuropeptides; 2015 Feb; 49():1-5. PubMed ID: 25464888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4/MyD88/NF-κB pathway: Molecular docking and biological investigations.
    ElSayed MH; Atif HM; Eladl MA; Elaidy SM; Helaly AMN; Hisham FA; Farag NE; Osman NMS; Ibrahiem AT; Khella HWZ; Bilasy SE; Albalawi MA; Helal MA; Alzlaiq WA; Zaitone SA
    Biomed Pharmacother; 2023 Aug; 164():114917. PubMed ID: 37244180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7.
    Wang X; Guan Q; Wang M; Yang L; Bai J; Yan Z; Zhang Y; Liu Z
    Drug Des Devel Ther; 2015; 9():2553-63. PubMed ID: 26089639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
    Kandil EA; Abdelkader NF; El-Sayeh BM; Saleh S
    Neuroscience; 2016 Sep; 332():26-37. PubMed ID: 27365173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
    Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
    Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson's disease.
    Palle S; Neerati P
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):445-453. PubMed ID: 29411055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of roscovitine against rotenone-induced parkinsonism.
    Chen Y; Hou Y; Ge R; Han J; Xu J; Chen J; Wang H
    Restor Neurol Neurosci; 2018; 36(5):629-638. PubMed ID: 30056439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.